Kyle Steiger
Corporate Officer/Principal bei VALEO PHARMA INC.
Vermögen: 1 261 $ am 30.04.2024
Profil
Kyle Steiger is a professional who currently holds the position of Chief Commercial Officer & Senior Vice President at Valeo Pharma, Inc. Prior to this, he worked as VP-Ophthalmology, Primary Care & Franchise at Novartis Pharmaceuticals Canada, Inc. and as Vice President-Commercial Services at Ashfield Healthcare Canada, Inc. He completed his undergraduate degree at Brock University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
0,02% | 29.11.2023 | 19 394 ( 0,02% ) | 1 261 $ | 30.04.2024 |
Aktive Positionen von Kyle Steiger
| Unternehmen | Position | Beginn |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 30.08.2022 |
Ehemalige bekannte Positionen von Kyle Steiger
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | - |
| Ashfield Healthcare Canada, Inc. | Corporate Officer/Principal | - |
Ausbildung von Kyle Steiger
| Brock University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
| Ashfield Healthcare Canada, Inc. |
